FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

New Sleep Apnea Indication for Lillys Zepbound

[ Price : $8.95]

FDA approves a new indication for Lillys Zepbound to treat some obese patients with obstructive sleep apnea.

Astellas Recalls Lots of Prograf and Astagraf

[ Price : $8.95]

FDA says Astellas has recalled one lot each of its Prograf and Astagraf transplant medications that may contain empty capsules.

FDA Approves Checkpoints Unloxcyt

[ Price : $8.95]

FDA approves Checkpoint Therapeutics Unloxcyt to treat some squamous cell cancer patients.

Axsome Plans Alzheimers NDA on Mixed Data

[ Price : $8.95]

Axsome Therapeutics plans an NDA submission for AXS-05 (dextromethorphan-bupropion) in the second half of next year for treating A...

Exclude Liraglutide from Compounding: Novo Nordisk

[ Price : $8.95]

Novo Nordisk petitions FDA to exclude its liraglutide from the agencys list of bulk drug substances that may be used by drug compo...

Mylan 6-Item Form FDA-483 Posted

[ Price : $8.95]

FDA posts a six-item Form FDA-483 that led to a 12/19 Warning Letter to Mylan Laboratories citing its Pradesh, India manufacturing...

FDA Approves Xcoverys Ensacove for Some Lung Cancers

[ Price : $8.95]

FDA approves Xcoverys Ensacove, an anaplastic lymphoma kinase inhibitor, to treat some non-small cell lung cancers.

FDA Approves Humacytes Symvess

[ Price : $8.95]

FDA approves Humacytes Symvess for use with some extremity arterial injuries.

FDA Alert on Boston Accolade Pacers Early Replacement

[ Price : $8.95]

FDA alerts patients, caregivers, and healthcare providers to the potential for some Boston Scientific Accolade pacemakers to need ...

CGMP Violations in Micro Orgo Chem Inspection

[ Price : $8.95]

FDA warns Indias Micro Orgo Chem about CGMP deviations in its production of active pharmaceutical ingredients.